An update review of cellular mechanisms conferring the indirect and direct effects of estrogen on articular cartilage

References

• Altman R, Asch E, Bloch D, et al. Development of criteria for the classification and reporting of osteoarthritis. Classification of osteoarthritis of the knee. Diagnostic and Therapeutic Criteria Committee of the American Rheumatism Association. Arthritis Rheum 1986; 29: 1039–1049
   PubMed Web of Science ®Google Scholar
• Woolf A D, Pfleger B. Burden of major musculoskeletal conditions. Bull World Health Organ 2003; 81: 646–656
   PubMed Web of Science ®Google Scholar
• Tankó L B, Karsdal M A, Christiansen C. The clinical potential of oestrogen for the prevention of osteoarthritis: What is known and what needs to be done?. Women's Health 2005; 1: 125–132
   Google Scholar
• Nevitt M C, Felson D T, Williams E N, Grady D. The effect of oestrogen plus progestin on knee symptoms and related disability in postmenopausal women: The Heart and Oestrogen/Progestin Replacement Study, a randomized, double-blind, placebo-controlled trial. Arthritis Rheum 2001; 44: 811–818
   PubMed Web of Science ®Google Scholar
• Maheu E, Dreiser R L, Guillou G B, Dewailly J. Hand osteoarthritis patients characteristics according to the existence of a hormone replacement therapy. Osteoarthritis Cartilage 2000; 8(Suppl A)S33–S37
   PubMedGoogle Scholar
• Oliveria S A, Felson D T, Klein R A, Reed J I, Walker A M. Oestrogen replacement therapy and the development of osteoarthritis. Epidemiology 1996; 7: 415–419
   PubMed Web of Science ®Google Scholar
• Von Muhlen D, Morton D, Von Muhlen C A, Barrett-Connor E. Postmenopausal oestrogen and increased risk of clinical osteoarthritis at the hip, hand, and knee in older women. J Womens Health Gend Based Med 2002; 11: 511–518
   PubMedGoogle Scholar
• Sandmark H, Hogstedt C, Lewold S, Vingard E. Osteoarthrosis of the knee in men and women in association with overweight, smoking, and hormone therapy. Ann Rheum Dis 1999; 58: 151–155
   PubMed Web of Science ®Google Scholar
• Sahyoun N R, Brett K M, Hochberg M C, Pamuk E R. Oestrogen replacement therapy and incidence of self-reported physician-diagnosed arthritis. Prev Med 1999; 28: 458–464
   PubMed Web of Science ®Google Scholar
• Parazzini F. Menopausal status, hormone replacement therapy use and risk of self-reported physician-diagnosed osteoarthritis in women attending menopause clinics in Italy. Maturitas 2003; 46: 207–212
   PubMed Web of Science ®Google Scholar
• Dennison E M, Arden N K, Kellingray S, Croft P, Coggon D, Cooper C. Hormone replacement therapy, other reproductive variables and symptomatic hip osteoarthritis in elderly white women: a case-control study. Br J Rheumatol 1998; 37: 1198–1202
   PubMedGoogle Scholar
• Nevitt M C, Cummings S R, Lane N E, et al. Association of oestrogen replacement therapy with the risk of osteoarthritis of the hip in elderly white women. Study of Osteoporotic Fractures Research Group. Arch Intern Med 1996; 156: 2073–2080
   PubMed Web of Science ®Google Scholar
• Spector T D, Nandra D, Hart D J, Doyle D V. Is hormone replacement therapy protective for hand and knee osteoarthritis in women?: The Chingford Study. Ann Rheum Dis 1997; 56: 432–434
   PubMed Web of Science ®Google Scholar
• Hannan M T, Felson D T, Anderson J J, Naimark A, Kannel W B. Estrogen use and radiographic osteoarthritis of the knee in women. The Framingham Osteoarthritis Study. Arthritis Rheum 1990; 33: 525–532
   PubMed Web of Science ®Google Scholar
• Zhang Y, McAlindon T E, Hannan M T, et al. Oestrogen replacement therapy and worsening of radiographic knee osteoarthritis: the Framingham Study. Arthritis Rheum 1998; 41: 1867–1873
   PubMed Web of Science ®Google Scholar
• Wluka A E, Davis S R, Bailey M, Stuckey S L, Cicuttini F M. Users of oestrogen replacement therapy have more knee cartilage than non-users. Ann Rheum Dis 2001; 60: 332–336
   PubMed Web of Science ®Google Scholar
• Cirillo D J, Wallace R B, Wu L, Yood R A. Effect of hormone therapy on risk of hip and knee joint replacement in the Women's Health Initiative. Arthritis Rheum 2006; 54: 3194–3204
   PubMed Web of Science ®Google Scholar
• Dougados M. Monitoring osteoarthritis progression and therapy. Osteoarthritis Cartilage 2004; 12(Suppl A)S55–S60
   PubMedGoogle Scholar
• Pelletier G. Localization of androgen and oestrogen receptors in rat and primate tissues. Histol Histopathol 2000; 15: 1261–1270
   PubMed Web of Science ®Google Scholar
• Richmond R S, Carlson C S, Register T C, Shanker G, Loeser R F. Functional oestrogen receptors in adult articular cartilage: oestrogen replacement therapy increases chondrocyte synthesis of proteoglycans and insulin-like growth factor binding protein 2. Arthritis Rheum 2000; 43: 2081–2090
   PubMed Web of Science ®Google Scholar
• Dayani N, Corvol M T, Robel P, et al. Oestrogen receptors in cultured rabbit articular chondrocytes: influence of age. J Steroid Biochem 1988; 31: 351–356
   PubMedGoogle Scholar
• Claassen H, Hassenpflug J, Schunke M, Sierralta W, Thole H, Kurz B. Immunohistochemical detection of oestrogen receptor alpha in articular chondrocytes from cows, pigs and humans: in situ and in vitro results. Ann Anat 2001; 183: 223–227
   PubMed Web of Science ®Google Scholar
• Ushiyama T, Ueyama H, Inoue K, Ohkubo I, Hukuda S. Expression of genes for oestrogen receptors alpha and beta in human articular chondrocytes. Osteoarthritis Cartilage 1999; 7: 560–566
   PubMed Web of Science ®Google Scholar
• Ushiyama T, Ueyama H, Inoue K, Nishioka J, Ohkubo I, Hukuda S. Oestrogen receptor gene polymorphism and generalized osteoarthritis. J Rheumatol 1998; 25: 134–137
   PubMed Web of Science ®Google Scholar
• Nasatzky E, Schwartz Z, Soskolne W A, et al. Evidence for receptors specific for 17 beta-oestradiol and testosterone in chondrocyte cultures. Connect Tissue Res 1994; 30: 277–294
   PubMed Web of Science ®Google Scholar
• Sylvia V L, Walton J, Lopez D, Dean D D, Boyan B D, Schwartz Z. 17 beta-oestradiol-BSA conjugates and 17 beta-oestradiol regulate growth plate chondrocytes by common membrane associated mechanisms involving PKC dependent and independent signal transduction. J Cell Biochem 2001; 81: 413–429
   PubMed Web of Science ®Google Scholar
• Evinger A J, III, Levin E R. Requirements for oestrogen receptor alpha membrane localization and function. Steroids 2005; 70: 361–363
   PubMed Web of Science ®Google Scholar
• Boyan B D, Schwartz Z. Rapid vitamin D-dependent PKC signaling shares features with estrogen-dependent PKC signaling in cartilage and bone. Steroids 2004; 69: 591–597
   PubMed Web of Science ®Google Scholar
• Sylvia V L, Hughes T, Dean D D, Boyan B D, Schwartz Z. 17β-Estradiol regulation of protein kinase C activity in chondrocytes is sex-dependent and involves nongenomic mechanisms. J Cell Physiol 1998; 176: 435–444
   PubMed Web of Science ®Google Scholar
• Cheng P, Ma X, Xue Y, Li S, Zhang Z. Effects of oestradiol on proliferation and metabolism of rabbit mandibular condylar cartilage cells in vitro. Chin Med J (Engl) 2003; 116: 1413–1417
   PubMed Web of Science ®Google Scholar
• Schwartz Z, Gates P A, Nasatzky E, et al. Effect of 17β-estradiol on chondrocyte membrane fluidity and phospholipid metabolism is membrane-specific, sex-specific, and cell maturation-dependent. Biochim Biophys Acta 1996; 1282: 1–10
   PubMed Web of Science ®Google Scholar
• Arevalo-Silva C A, Cao Y, Weng Y, et al. The effect of fibroblast growth factor and transforming growth factor-beta on porcine chondrocytes and tissue-engineered autologous elastic cartilage. Tissue Eng 2001; 7: 81–88
   PubMedGoogle Scholar
• Cheung W H, Lee K M, Fung K P, Lui P Y, Leung K S. TGF-beta1 is the factor secreted by proliferative chondrocytes to inhibit neo-angiogenesis. J Cell Biochem Suppl 2001, Suppl 36: 79–88
   PubMedGoogle Scholar
• Gatherer D, ten Dijke P, Baird D T, Akhurst R J. Expression of TGF-beta isoforms during first trimester human embryogenesis. Development 1990; 110: 445–460
   PubMed Web of Science ®Google Scholar
• Im G I, Kim D Y, Shin J H, Hyun C W, Cho W H. Repair of cartilage defect in the rabbit with cultured mesenchymal stem cells from bone marrow. J Bone Joint Surg Br 2001; 83: 289–294
   PubMed Web of Science ®Google Scholar
• Yang X, Chen L, Xu X, Li C, Huang C, Deng C X. TGF-beta/Smad3 signals repress chondrocyte hypertrophic differentiation and are required for maintaining articular cartilage. J Cell Biol 2001; 153: 35–46
   PubMed Web of Science ®Google Scholar
• Gokhale J A, Frenkel S R, DiCesare P E. Estrogen and osteoarthritis. Am J Orthop 2004; 33: 71–80
   PubMedGoogle Scholar
• Saggese G, Federico G, Cinquanta L. In vitro effects of growth hormone and other hormones on chondrocytes and osteoblast-like cells. Acta Paediatr Suppl 1993; 82(Suppl 391)54–59
   PubMedGoogle Scholar
• Nasatzky E, Grinfeld D, Boyan B D, Dean D D, Ornoy A, Schwartz Z. Transforming growth factor-beta1 modulates chondrocyte responsiveness to 17beta-oestradiol. Endocrine 1999; 11: 241–249
   PubMed Web of Science ®Google Scholar
• Yaeger P C, Masi T L, de Ortiz J L, Binette F, Tubo R, McPherson J M. Synergistic action of transforming growth factor-beta and insulin-like growth factor-I induces expression of type II collagen and aggrecan genes in adult human articular chondrocytes. Exp Cell Res 1997; 237: 318–325
   PubMed Web of Science ®Google Scholar
• Kondo S, Cha S H, Xie W F, Sandell L J. Cytokine regulation of cartilage-derived retinoic acid-sensitive protein (CD-RAP) in primary articular chondrocytes: suppression by IL-1, bfGF, TGFbeta and stimulation by IGF-1. J Orthop Res 2001; 19: 712–719
   PubMed Web of Science ®Google Scholar
• Fernihough J K, Richmond R S, Carlson C S, Cherpes T, Holly J M, Loeser R F. Oestrogen replacement therapy modulation of the insulin-like growth factor system in monkey knee joints. Arthritis Rheum 1999; 42: 2103–2111
   PubMed Web of Science ®Google Scholar
• Pfeilschifter J, Koditz R, Pfohl M, Schatz H. Changes in proinflammatory cytokine activity after menopause. Endocr Rev 2002; 23: 90–119
   PubMed Web of Science ®Google Scholar
• Chambers M G, Bayliss M T, Mason R M. Chondrocyte cytokine and growth factor expression in murine osteoarthritis. Osteoarthritis Cartilage 1997; 5: 301–308
   PubMed Web of Science ®Google Scholar
• Guerne P A, Carson D A, Lotz M. IL-6 production by human articular chondrocytes. Modulation of its synthesis by cytokines, growth factors, and hormones in vitro. J Immunol 1990; 144: 499–505
   PubMed Web of Science ®Google Scholar
• Le Bail J, Liagre B, Vergne P, Bertin P, Beneytout J, Habrioux G. Aromatase in synovial cells from postmenopausal women. Steroids 2001; 66: 749–757
   PubMed Web of Science ®Google Scholar
• Badger A M, Blake S M, Dodds R A, et al. Idoxifene, a novel selective oestrogen receptor modulator, is effective in a rat model of adjuvant-induced arthritis. J Pharmacol Exp Ther 1999; 291: 1380–1386
   PubMed Web of Science ®Google Scholar
• Richette P, Dumontier M F, Francois M, et al. Dual effects of 17beta-oestradiol on interleukin 1beta-induced proteoglycan degradation in chondrocytes. Ann Rheum Dis 2004; 63: 191–199
   PubMed Web of Science ®Google Scholar
• Lee Y J, Lee E B, Kwon Y E, et al. Effect of oestrogen on the expression of matrix metalloproteinase (MMP)-1, MMP-3, and MMP-13 and tissue inhibitor of metalloproteinase-1 in osteoarthritis chondrocytes. Rheumatol Int 2003; 23: 282–288
   PubMed Web of Science ®Google Scholar
• Lu T, Achari Y, Sciore P, Hart D A. Oestrogen receptor alpha regulates matrix metalloproteinase-13 promoter activity primarily through the AP-1 transcriptional regulatory site. Biochim Biophys Acta 2006; 1762: 719–731
   PubMed Web of Science ®Google Scholar
• Song Y J, Wu Z H, Lin S Q, Weng X S, Qiu G X. [The effect of oestrogen and progestin on the expression of matrix metalloproteinases, tissue inhibitor of metalloproteinase and interleukin-1beta mRNA in synovia of OA rabbit model]. Zhonghua Yi Xue Za Zhi 2003; 83: 498–503
   PubMedGoogle Scholar
• Mazzetti I, Grigolo B, Pulsatelli L, et al. Differential roles of nitric oxide and oxygen radicals in chondrocytes affected by osteoarthritis and rheumatoid arthritis. Clin Sci (Lond) 2001; 101: 593–599
   PubMed Web of Science ®Google Scholar
• Bates E J, Lowther D A, Handley C J. Oxygen free-radicals mediate an inhibition of proteoglycan synthesis in cultured articular cartilage. Ann Rheum Dis 1984; 43: 462–469
   PubMed Web of Science ®Google Scholar
• Schalkwijk J, Van den Berg W B, van de Putte L B, Joosten L A. Hydrogen peroxide suppresses the proteoglycan synthesis of intact articular cartilage. J Rheumatol 1985; 12: 205–210
   PubMed Web of Science ®Google Scholar
• Tiku M L, Gupta S, Deshmukh D R. Aggrecan degradation in chondrocytes is mediated by reactive oxygen species and protected by antioxidants. Free Radic Res 1999; 30: 395–405
   PubMed Web of Science ®Google Scholar
• Liehr J G, Roy D. Pro-oxidant and antioxidant effects of oestrogens. Free Radical and Antioxidant Protocols, D Armstrong. Humana, Totowa 1998; 425–435
   Google Scholar
• Ayres S, Tang M, Subbiah M T. Oestradiol-17beta as an antioxidant: some distinct features when compared with common fat-soluble antioxidants. J Lab Clin Med 1996; 128: 367–375
   PubMed Web of Science ®Google Scholar
• Claassen H, Schunke M, Kurz B. Oestradiol protects cultured articular chondrocytes from oxygen-radical-induced damage. Cell Tissue Res 2005; 319: 439–445
   PubMed Web of Science ®Google Scholar
• Palmer R M, Hickery M S, Charles I G, Moncada S, Bayliss M T. Induction of nitric oxide synthase in human chondrocytes. Biochem Biophys Res Commun 1993; 193: 398–405
   PubMed Web of Science ®Google Scholar
• Grabowski P S, Macpherson H, Ralston S H. Nitric oxide production in cells derived from the human joint. Br J Rheumatol 1996; 35: 207–212
   PubMedGoogle Scholar
• Melchiorri C, Meliconi R, Frizziero L, et al. Enhanced and coordinated in vivo expression of inflammatory cytokines and nitric oxide synthase by chondrocytes from patients with osteoarthritis. Arthritis Rheum 1998; 41: 2165–2174
   PubMed Web of Science ®Google Scholar
• Cuzzocrea S, Mazzon E, Dugo L, et al. Inducible nitric oxide synthase mediates bone loss in ovariectomized mice. Endocrinology 2003; 144: 1098–1107
   PubMed Web of Science ®Google Scholar
• Josefsson E, Tarkowski A. Suppression of type II collagen-induced arthritis by the endogenous oestrogen metabolite 2-methoxyoestradiol. Arthritis Rheum 1997; 40: 154–163
   PubMed Web of Science ®Google Scholar
• Correale J, Arias M, Gilmore W. Steroid hormone regulation of cytokine secretion by proteolipid protein-specific CD4+ T cell clones isolated from multiple sclerosis patients and normal control subjects. J Immunol 1998; 161: 3365–3374
   PubMed Web of Science ®Google Scholar
• Hui W, Rowan A D, Richards C D, Cawston T E. Oncostatin M in combination with tumor necrosis factor alpha induces cartilage damage and matrix metalloproteinase expression in vitro and in vivo. Arthritis Rheum 2003; 48: 3404–3418
   PubMed Web of Science ®Google Scholar
• Sondergaard B C, Henriksen K, Wulf H, et al. Relative contribution of matrix metalloprotease and cysteine protease activities to cytokine-stimulated articular cartilage degradation. Osteoarthritis Cartilage 2006; 14: 738–748
   PubMed Web of Science ®Google Scholar
• Oestergaard S, Sondergaard B C, Hoegh-Andersen P, et al. Effects of ovariectomy and oestrogen therapy on type II collagen degradation and structural integrity of articular cartilage in rats: implications of the time of initiation. Arthritis Rheum 2006; 54: 2441–2451
   PubMed Web of Science ®Google Scholar
• Englert C, Blunk T, Fierlbeck J, et al. Steroid hormones strongly support bovine articular cartilage integration in the absence of interleukin-1beta. Arthritis Rheum 2006; 54: 3890–3897
   PubMed Web of Science ®Google Scholar
• Ham K D, Carlson C S. Effects of oestrogen replacement therapy on bone turnover in subchondral bone and epiphyseal metaphyseal cancellous bone of ovariectomized cynomolgus monkeys. J Bone Miner Res 2004; 19: 823–829
   PubMed Web of Science ®Google Scholar
• Hoegh-Andersen P, Tanko L B, Andersen T L, et al. Ovariectomized rats as a model of postmenopausal osteoarthritis: validation and application. Arthritis Res Ther 2004; 6: R169–R180
   PubMed Web of Science ®Google Scholar
• Christgau S, Tanko L B, Cloos P A, et al. Suppression of elevated cartilage turnover in postmenopausal women and in ovariectomized rats by estrogen and a selective estrogen-receptor modulator (SERM). Menopause 2004; 11: 508–518
   PubMed Web of Science ®Google Scholar
• Ren Y X, Deng Y Z. [An experimental study on effect of oestrogen on osteoarthritis in female rats]. Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi 2003; 17: 212–214
   PubMedGoogle Scholar
• Turner A S, Athanasiou K A, Zhu C F, Alvis M R, Bryant H U. Biochemical effects of oestrogen on articular cartilage in ovariectomized sheep. Osteoarthritis Cartilage 1997; 5: 63–69
   PubMed Web of Science ®Google Scholar
• Rosner I A, Goldberg V M, Getzy L, Moskowitz R W. Effects of oestrogen on cartilage and experimentally induced osteoarthritis. Arthritis Rheum 1979; 22: 52–58
   PubMed Web of Science ®Google Scholar
• Rosner I A, Malemud C J, Goldberg V M, Papay R S, Getzy L, Moskowitz R W. Pathologic and metabolic responses of experimental osteoarthritis to oestradiol and an oestradiol antagonist. Clin Orthop Relat Res 1982; 280–286
   PubMed Web of Science ®Google Scholar
• Ham K D, Loeser R F, Lindgren B R, Carlson C S. Effects of long-term oestrogen replacement therapy on osteoarthritis severity in cynomolgus monkeys. Arthritis Rheum 2002; 46: 1956–1964
   PubMed Web of Science ®Google Scholar
• Tsai C L, Liu T K. Oestradiol-induced knee osteoarthrosis in ovariectomized rabbits. Clin Orthop Relat Res 1993; 291: 295–302
   PubMed Web of Science ®Google Scholar
• Tsai C L, Liu T K. Inhibition of oestradiol-induced early osteoarthritic changes by tamoxifen. Life Sci 1992; 50: 1943–1951
   PubMed Web of Science ®Google Scholar
• Rossouw J E, Anderson G L, Prentice R L, et al. Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results from the Women's Health Initiative randomized controlled trial. JAMA 2002; 288: 321–333
   PubMed Web of Science ®Google Scholar
• Anderson G L, Limacher M, Assaf A R, et al. Effects of conjugated equine estrogen in postmenopausal women with hysterectomy: the Women's Health Initiative randomized controlled trial. JAMA 2004; 291: 1701–1712
   PubMed Web of Science ®Google Scholar
• Estrogen and progestogen use in peri- and postmenopausal women: March 2007 Position Statement of The North American Menopause Society. Menopause 2007; 14: 168–182
   PubMed Web of Science ®Google Scholar
• Ettinger B, Ensrud K E, Wallace R, et al. Effects of ultralow-dose transdermal oestradiol on bone mineral density: a randomized clinical trial. Obstet Gynecol 2004; 104: 443–51
   PubMed Web of Science ®Google Scholar